SAN FRANCISCO – Hyde Park Capital announced that Infiniti Medical LLC and its subsidiary, Orthomed UK Ltd, two globally recognized brands specializing in veterinary interventional radiology, cardiology, soft tissue surgery, and orthopedics, have been acquired by Creative Science, a CIMA Animal Health company and portfolio company of Incline Equity Partners.
Hyde Park Capital, led by Managing Director Craig Lawson, served as the exclusive financial advisor to Infiniti Medical for this transaction.
Expanding Innovation in Veterinary Medicine
The acquisition reinforces Creative Science’s commitment to advancing veterinary medicine through cutting-edge solutions. Infiniti Medical and Orthomed have long been at the forefront of animal health technology, supplying veterinarians worldwide with high-quality, innovative medical products.
Lynn Snodgrass, CEO of CIMA Animal Health, stated:
“This acquisition represents an exciting opportunity to expand our impact on veterinary medicine. Infiniti Medical and Orthomed are trailblazers in their respective fields, and by joining forces, we can accelerate innovation and provide even greater value to veterinary professionals worldwide.”
A Legacy of Veterinary Innovation
Founded in Silicon Valley, Infiniti Medical has pioneered advancements in veterinary medical technology, from its revolutionary Vet Stent solutions to developments in diagnostics, telemedicine, and digital health.
Meanwhile, Orthomed has built a strong reputation over the past 15 years for its high-quality orthopedic implants and instruments, consistently raising the standard for surgical precision in veterinary care.
Jared Finegold, CEO of Infiniti Medical, shared his enthusiasm for the partnership:
“Infiniti Medical was founded on the belief that advanced technology could revolutionize veterinary medicine. By partnering with Creative Science, we will continue to scale our efforts, invest further in veterinary medical device innovations, and accelerate our development of cutting-edge technologies and training solutions for veterinarians across the globe.”
Strategic Advisory by Hyde Park Capital
Craig Lawson, Managing Director at Hyde Park Capital, highlighted the significance of the transaction:
“Infiniti Medical and Orthomed have built an outstanding legacy of innovation in veterinary medicine. This partnership with Creative Science is a natural fit and positions these brands for even greater success. We are proud to have advised Infiniti Medical on this strategic move and look forward to seeing the impact this collaboration will have on the future of veterinary care.”
The partnership will enable Infiniti Medical and Orthomed to expand their global reach, enhance R&D efforts, and deliver even greater value to veterinarians and pet owners worldwide.
